Edwin Miranda entitled VP of Cytovance’s Quality Biologics

Cytovance Biologics a biopharmaceutical contract manufacturer of mammalian and microbial biologics proclaimed Edwin Miranda as Vice-President of Quality.

Dr. Jesse McCool, Sr. Vice President of Research & Development.  “With over 33 years’ experience in the biopharmaceutical contract manufacturing industry, Edwin brings a depth of experience in quality assurance, encompassing solid & liquid oral dose, biologics and cosmetics. We are very fortunate to have such a well-seasoned and experienced executive join our team.  Edwin’s knowledge and leadership skills will be tremendous assets to the Company.”

His former stints include supervising the Quality Assurance team in a successful FDA approval and launch of the New Drug Application (NDA) for Keppra. He has served as Director of Quality or Vice President of Quality Assurance URL Mutual Pharmaceuticals, Inc., Legacy Pharmaceutical Packaging, and Piramal Critical Care, Inc. In these roles, he managed the quality systems, oversaw regulatory compliance functions, and developed a successful remediation plan to correct 483 observations, resulting in receipt of an Establishment Inspection Report (EIR) in good standing. Edwin, an army veteran,  holds a B.S. in Biology & Chemistry from Angelo State University in San Angelo, TX.